Lorie M Harper1, Victoria Jauk2, Sherri Longo3, Joseph R Biggio4, Jeff M Szychowski2, Alan T Tita2. 1. Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL. Electronic address: lmharper@uabmc.edu. 2. Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL. 3. Women's Services Center of Excellence, Ochsner Health System, New Orleans, LA. 4. Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL; Women's Services Center of Excellence, Ochsner Health System, New Orleans, LA.
Abstract
BACKGROUND: Although in 2013 the American College of Obstetricians and Gynecologists recommended early screening for gestational diabetes in obese women, no studies demonstrate an improvement in perinatal outcomes with this strategy. OBJECTIVE: We sought to determine whether early screening for gestational diabetes improves perinatal outcomes in obese women. MATERIALS AND METHODS: Randomized controlled trial comparing early gestational diabetes screening (14-20 weeks) to routine screening (24-28 weeks) in obese women (body mass index ≥30 kg/m2) at 2 tertiary care centers in the United States. Screening was performed using a 50-g, 1-hour glucose challenge test followed by a 100-g, 3-hour glucose tolerance test if the initial screen was ≥135 mg/dL. Gestational diabetes was diagnosed using Carpenter-Coustan criteria. Women not diagnosed at 14 to 20 weeks were rescreened at 24 to 28 weeks. Exclusion criteria were pre-existing diabetes, major medical illness, bariatric surgery, and prior cesarean delivery. The primary outcome was a composite of macrosomia (>4000 g), primary cesarean delivery, hypertensive disease of pregnancy, shoulder dystocia, neonatal hyperbilirubinemia, and neonatal hypoglycemia (assessed within 48 hours of birth). RESULTS:A total of 962 women were randomized, and outcomes were available for 922. Of these 922 women, 459 (49.8%) were assigned to early screen and 463 (50.2%) to routine screen. Baseline characteristics were balanced between groups. In the early screening group, 69 (15.0%; 95% confidence interval, 11.9-18.6%) were diagnosed with gestational diabetes: 29 (6.3%; 95% confidence interval, 4.3-8.9%) at <20 weeks and 40 (8.7%; 95% confidence interval, 6.3-11.7%) at >24 weeks. Of those randomized to routine screening, 56 (12.1%; 95% confidence interval, 9.3-15.4%) had gestational diabetes. Early screening did not reduce the incidence of the primary outcome (56.9% in the early screen versus 50.8% in the routine screen, P = .07; relative risk, 1.12; 95% confidence interval, 0.99-1.26). CONCLUSION: Early screening for gestational diabetes in obese women did not reduce the composite perinatal outcome.
RCT Entities:
BACKGROUND: Although in 2013 the American College of Obstetricians and Gynecologists recommended early screening for gestational diabetes in obesewomen, no studies demonstrate an improvement in perinatal outcomes with this strategy. OBJECTIVE: We sought to determine whether early screening for gestational diabetes improves perinatal outcomes in obesewomen. MATERIALS AND METHODS: Randomized controlled trial comparing early gestational diabetes screening (14-20 weeks) to routine screening (24-28 weeks) in obesewomen (body mass index ≥30 kg/m2) at 2 tertiary care centers in the United States. Screening was performed using a 50-g, 1-hour glucose challenge test followed by a 100-g, 3-hour glucose tolerance test if the initial screen was ≥135 mg/dL. Gestational diabetes was diagnosed using Carpenter-Coustan criteria. Women not diagnosed at 14 to 20 weeks were rescreened at 24 to 28 weeks. Exclusion criteria were pre-existing diabetes, major medical illness, bariatric surgery, and prior cesarean delivery. The primary outcome was a composite of macrosomia (>4000 g), primary cesarean delivery, hypertensive disease of pregnancy, shoulder dystocia, neonatal hyperbilirubinemia, and neonatal hypoglycemia (assessed within 48 hours of birth). RESULTS: A total of 962 women were randomized, and outcomes were available for 922. Of these 922 women, 459 (49.8%) were assigned to early screen and 463 (50.2%) to routine screen. Baseline characteristics were balanced between groups. In the early screening group, 69 (15.0%; 95% confidence interval, 11.9-18.6%) were diagnosed with gestational diabetes: 29 (6.3%; 95% confidence interval, 4.3-8.9%) at <20 weeks and 40 (8.7%; 95% confidence interval, 6.3-11.7%) at >24 weeks. Of those randomized to routine screening, 56 (12.1%; 95% confidence interval, 9.3-15.4%) had gestational diabetes. Early screening did not reduce the incidence of the primary outcome (56.9% in the early screen versus 50.8% in the routine screen, P = .07; relative risk, 1.12; 95% confidence interval, 0.99-1.26). CONCLUSION: Early screening for gestational diabetes in obesewomen did not reduce the composite perinatal outcome.
Authors: Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson Journal: N Engl J Med Date: 2005-06-12 Impact factor: 91.245
Authors: Mark B Landon; Madeline Murguia Rice; Michael W Varner; Brian M Casey; Uma M Reddy; Ronald J Wapner; Dwight J Rouse; Joseph R Biggio; John M Thorp; Edward K Chien; George Saade; Alan M Peaceman; Sean C Blackwell; J Peter VanDorsten Journal: Diabetes Care Date: 2014-11-20 Impact factor: 19.112
Authors: Milana A Bochkur Dratver; Juliana Arenas; Tanayott Thaweethai; Chu Yu; Kaitlyn James; Emily A Rosenberg; Michael J Callahan; Melody Cayford; Jessica S Tangren; Sarah N Bernstein; Marie France Hivert; Ravi Thadhani; Camille E Powe Journal: Diabetologia Date: 2021-12-30 Impact factor: 10.122
Authors: Teresa A Hillier; Kathryn L Pedula; Keith K Ogasawara; Kimberly K Vesco; Caryn Oshiro; Jan L Van Marter Journal: J Perinat Med Date: 2022-05-11 Impact factor: 2.716
Authors: Leanne M Redman; Kimberly L Drews; Samuel Klein; Linda Van Horn; Rena R Wing; Xavier Pi-Sunyer; Mary Evans; Kaumudi Joshipura; S Sonia Arteaga; Alison G Cahill; Rebecca G Clifton; Kimberly A Couch; Paul W Franks; Dympna Gallagher; Debra Haire-Joshu; Corby K Martin; Alan M Peaceman; Suzanne Phelan; Elizabeth A Thom; Susan Z Yanovski; William C Knowler Journal: Diabetes Res Clin Pract Date: 2020-11-22 Impact factor: 8.180
Authors: Latife Bozkurt; Christian S Göbl; Karoline Leitner; Giovanni Pacini; Alexandra Kautzky-Willer Journal: BMJ Open Diabetes Res Care Date: 2020-11
Authors: Le Minh Tu Phan; Thuy Anh Thu Vo; Thi Xoan Hoang; Sathish Panneer Selvam; Hoang Lan Pham; Jae Young Kim; Sungbo Cho Journal: Adv Mater Technol Date: 2021-05-06